A detailed history of Carlson Capital L P transactions in Catalent, Inc. stock. As of the latest transaction made, Carlson Capital L P holds 45,000 shares of CTLT stock, worth $2.71 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
45,000
Previous 209,809 78.55%
Holding current value
$2.71 Million
Previous $11.8 Million 78.64%
% of portfolio
0.41%
Previous 1.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$53.58 - $57.02 $8.83 Million - $9.4 Million
-164,809 Reduced 78.55%
45,000 $2.53 Million
Q1 2024

May 14, 2024

BUY
$42.56 - $59.82 $8.93 Million - $12.6 Million
209,809 New
209,809 $11.8 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Carlson Capital L P Portfolio

Follow Carlson Capital L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carlson Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Carlson Capital L P with notifications on news.